Rosiglitazone inhibits angiotensin II-induced C-reactive protein production in human aortic endothelial cells through regulating AT(1)-ROS-MAPK signal pathway. [electronic resource]
Producer: 20130103Description: 1031-7 p. digitalISSN:- 1420-908X
- Angiotensin I -- metabolism
- Angiotensin II -- metabolism
- Anti-Inflammatory Agents -- pharmacology
- Aorta -- cytology
- C-Reactive Protein -- genetics
- Cells, Cultured
- Endothelial Cells -- drug effects
- Humans
- Mitogen-Activated Protein Kinases -- metabolism
- PPAR gamma -- agonists
- RNA, Messenger -- metabolism
- Reactive Oxygen Species -- metabolism
- Rosiglitazone
- Thiazolidinediones -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.